tradingkey.logo
tradingkey.logo
Search

Neurocrine nears $2.5 billion deal for Soleno Therapeutics, FT reports

ReutersApr 6, 2026 2:55 AM

- Drugmaker Neurocrine Biosciences NBIX.O is nearing a more than $2.5 billion acquisition of Soleno Therapeutics SLNO.O, the Financial Time reported on Sunday.

Reuters could not immediately confirm the report.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI